Abstract

In young patients with acute pulmonary embolism (PE), the predictive value of currently available prognostic tools has not been evaluated. Our objective was to compare prognostic value of 7 available tools (GPS, PESI, sPESI, Prognostic Algorithm, PREP, shock index and RIETE) in patients aged <50 years. We used the RIETE database, including PE patients from 2001 to 2017. The major outcome was 30-day all-cause mortality. Of 34,651 patients with acute PE, 5,822 (17%) were aged <50 years. Of these, 83 (1.4%) died during the first 30 days. Number of patients deemed low risk with tools was: PREP (95.9%), GPS (89.6%), PESI (87.2%), Shock index (70.9%), sPESI (59.4%), Prognostic algorithm (58%) and RIETE score (48.6%). The tools with a highest sensitivity were: Prognostic Algorithm (91.6%; 95% CI: 85.6–97.5), RIETE score (90.4%; 95%CI: 84.0–96.7) and sPESI (88%; 95% CI: 81–95). The RIETE, Prognostic Algorithm and sPESI scores obtained the highest overall sensitivity estimates for also predicting 7- and 90-day all-cause mortality, 30-day PE-related mortality, 30-day major bleeding and 30-day VTE recurrences. The proportion of low-risk patients who died within the first 30 days was lowest using the Prognostic Algorithm (0.2%), RIETE (0.3%) or sPESI (0.3%) scores. In PE patients less 50 years, 30-day mortality was low. Although sPESI, RIETE and Prognostic Algorithm scores were the most sensitive tools to identify patients at low risk to die, other tools should be evaluated in this population to obtain more efficient results.

Highlights

  • In young patients with acute pulmonary embolism (PE), the predictive value of currently available prognostic tools has not been evaluated

  • Patients included in the RIETE registry we deemed eligible in presence of acute symptomatic PE confirmed by objective testing

  • Of the 34,651 patients with acute PE enrolled in RIETE by August 2017, 5,822 (17%) were aged

Read more

Summary

Introduction

In young patients with acute pulmonary embolism (PE), the predictive value of currently available prognostic tools has not been evaluated. Data on the clinical presentation, treatment, and outcomes during the course of anticoagulation in young patients with PE remain scarce Mortality in this population is low, the impact in terms of avoidable deaths and complications is relevant. It remains unclear whether the widely available risk prediction tools (e.g., PESI, sPESI, and others) – primarily validated in older patients with a high burden of co-morbidities – do perform well in the young[9]. The aim of this study was to compare seven currently available prognostic tools in terms of their ability to identify low-risk patients with acute PE aged

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call